Where will this product fit in the larger health care arena?
How will this product meet the Food and Drug Administration (FDA) “safe and effective” standards, as well as payors’ “reasonable and necessary” requirements?
How can the reimbursement strategy support the company’s overall objectives?
KeywordsMedical Policy Medicare Population Coverage Decision Reimbursement Strategy Medicare Coverage
Unable to display preview. Download preview PDF.